The biodistribution of metaiodobenzylguanidine
- 31 January 1992
- journal article
- case report
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 22 (1) , 46-48
- https://doi.org/10.1016/s0001-2998(05)80157-6
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- 123I metaiodobenzylguanidine (MIBG) scintigraphy of retinoblastoma: preliminary experience.British Journal of Ophthalmology, 1989
- Metaiodobenzylguanidine (MIBG) labeled with 123I/131I in neuroblastoma diagnosis and follow‐up treatment with a review of the diagnostic results of the international workshop of pediatric oncology held in Rome, september 1986Medical and Pediatric Oncology, 1987
- Radiochemistry, biochemistry, and kinetics of 131I‐metaiodobenzylguanidine (MIBG) and 123I‐MIBG: Clinical implications of the use of 123I‐MIBGMedical and Pediatric Oncology, 1987
- Radio-iodobenzylguanidine for the scintigraphic location and therapy of adrenergic tumorsSeminars in Nuclear Medicine, 1985
- Localization of m-iodo(131I)benzylguanidine in neuroblastomaAmerican Journal of Roentgenology, 1984
- IMAGING OF MEDULLARY THYROID CANCER WITH 131I-MIBGThe Lancet, 1984
- SCINTIGRAPHIC IMAGING OF CARCINOID TUMOURS WITH 131I-METAIODOBENZYLGUANIDINEThe Lancet, 1984
- Scintigraphic Localization of PheochromocytomaNew England Journal of Medicine, 1981
- Spectrum of Pheochromocytoma in Multiple Endocrine NeoplasiaAnnals of Internal Medicine, 1981